SCHEMBL18663282

SCHEMBL18663282

COC(=O)C1(C(=O)OC)C(C2=CCCCC2)=C(c2ccc(C(C)=O)cc2)c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ MAPT P10636 3/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ HSP90AA1 P07900 1/20 0.32
▸ HSP90AB1 P08238 1/20 0.32
▸ ESR1 P03372 1/20 0.31
▸ ESR2 Q92731 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ ACMSD Q8TDX5 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ PDK2 Q15119 1/20 0.30
▸ OPRK1 P41145 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ P2RX3 P56373 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18663404 0.81 MAPT (0.46) L3MBTL1MAPTSMN1; SMN2HSP90AA1HSP90AB1
SCHEMBL11816684 0.71 ACMSD (0.51) PTGS2SLC6A3L3MBTL1MAPTSMN1; SMN2
SCHEMBL11856263 0.70 ACMSD (0.50) PTGS2SLC6A3L3MBTL1MAPTSMN1; SMN2
SCHEMBL11673820 0.70 ACMSD (0.50) PTGS2SLC6A3L3MBTL1MAPTSMN1; SMN2
SCHEMBL11856256 0.70 ACMSD (0.50) PTGS2SLC6A3L3MBTL1MAPTSMN1; SMN2
SCHEMBL19690413 0.70 SMN1; SMN2 (0.43) MAPTSMN1; SMN2ALDH1A1KDM4EPDK2
SCHEMBL18663367 0.69 FGFR1 (0.39) L3MBTL1MAPTSMN1; SMN2HSP90AA1HSP90AB1
SCHEMBL18663286 0.69 CXCR5 (0.33) SLC6A3MAPTSMN1; SMN2ACMSD
SCHEMBL26352572 0.67 ACMSD (0.50) SLC6A3L3MBTL1MAPTSMN1; SMN2ALDH1A1
SCHEMBL19690698 0.66 GAA (0.38) SLC6A3SMN1; SMN2HSP90AA1HSP90AB1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170088642-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST CONTAINING CATALYST COMPONENT AND USE THEREOF BEIJING LIHE TECH LTD (CN) 2017-03-30 — — US claimed
US-20170088642-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST CONTAINING CATALYST COMPONENT AND USE THEREOF BEIJING LIHE TECH LTD (CN) 2017-03-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088642-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST CONTAINING CATALYST COMPONENT AND USE THEREOF TEC, DGAT2, MOGAT2 PTGS2 483/4885SLC6A3 3440/4885L3MBTL1 3906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback